Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K1 | Q92918 | 7/20 | 0.54 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.42 |
| ▸ | GSK3B | P49841 | 7/20 | 0.41 |
| ▸ | DYRK1A | Q13627 | 7/20 | 0.41 |
| ▸ | WNT1 | P04628 | 5/20 | 0.41 |
| ▸ | IKBKB | O14920 | 1/20 | 0.40 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.39 |
| ▸ | ABL1 | P00519 | 2/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1633642 | 0.87 | MAP3K5 (0.48) | MAP4K1MAP3K5GSK3BDYRK1AWNT1 | |
| SCHEMBL1634760 | 0.80 | MAP3K5 (0.54) | MAP4K1MAP3K5GSK3BDYRK1AWNT1 | |
| SCHEMBL1633623 | 0.79 | TBK1 (0.51) | GSK3BDYRK1AWNT1IKBKB | |
| SCHEMBL1633616 | 0.78 | IKBKB (0.48) | MAP4K1DYRK1AIKBKB | |
| SCHEMBL1633434 | 0.78 | HRH3 (0.43) | SCN9A | |
| SCHEMBL1634539 | 0.78 | IKBKB (0.44) | MAP4K1GSK3BDYRK1AWNT1IKBKB | |
| SCHEMBL12724910 | 0.78 | SYK (0.49) | IKBKB | |
| SCHEMBL1632083 | 0.77 | IKBKB (0.47) | IKBKB | |
| SCHEMBL1634175 | 0.77 | SYK (0.53) | IKBKB | |
| SCHEMBL1633269 | 0.76 | IKBKB (0.48) | DYRK1AIKBKB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7932262-B2 | Quinazolines for PDK1 inhibition | NOVARTIS AG (CH) | 2011-04-26 | — | — | US | disclosed |
| US-7932262-B2 | Quinazolines for PDK1 inhibition | NOVARTIS AG (CH) | 2011-04-26 | — | — | US | disclosed |
| US-7932262-B2 | Quinazolines for PDK1 inhibition | NOVARTIS AG (CH) | 2011-04-26 | — | — | US | disclosed |